NewsPatients needed for national pyoderma gangrenosum trial

Patients needed for national pyoderma gangrenosum trial

Skin integrity

Patients needed for national pyoderma gangrenosum trialThe STOP GAP Trial (Study of Treatments for Pyoderma Gangrenosum patients) is a multi-centre national trial investigating the two most common treatments for pyoderma gangrenosum (PG), a rare ulcerative skin condition.

One hundred and forty patients are needed by October 2012.  Currently, 99 patients have been recruited.  The trial is looking for patients with PG who are not currently being treated with either prednisolone (a steroid) or ciclosporin (an immunosuppressant).  There is also a parallel observational study which is recruiting patients who benefit from topical therapy, such as Dermovate or Protopic.

If you see patients with PG, please do consider referring them to a recruiting centre. For further information, including where patients are being recruited from, please contact the co-ordinating centre:

Eleanor Mitchell, Trial Manager
Telephone: 0115 8844926

Click here to view the STOPGAP trial website.

Join the Facebook page here.

 

The trial is managed by the Nottingham Clinical Trials Unit and the UK Dermatology Clinical Trials Network, and funded by the Department of Health via the National Institute for Health Research.

The STOP GAP Trial presents independent research commissioned by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10177).